Showing results (321-330 of 375) with videos related to

Sort By:
Pageof 38
Developmental Cell|April 5, 2014
PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium functionIrene Franco, Federico Gulluni, Carlo C Campa, et al.
Nature Medicine|August 30, 2005
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritisMontserrat Camps, Thomas Rückle, Hong Ji, et al.
Molecular Cancer Therapeutics|September 23, 2021
Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and ResistanceCélia Cintas, Thibault Douche, Zahra Dantes, et al.
Cell Reports. Medicine|December 5, 2023
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophyErica Mina, Elisabeth Wyart, Roberta Sartori, et al.
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administrationNadia Moretto, Paola Caruso, Raffaella Bosco, et al.
Journal of Proteome Research|May 12, 2010
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancerBarbara Tomaino, Paola Cappello, Michela Capello, et al.
Pageof 38